GEMINI THERAPEUTICS INC (GMTX) Stock Analyst Earnings Estimates
NASDAQ:GMTX - Nasdaq - US36870G1058 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A | ||||
| EBITDA YoY % growth | N/A | N/A | -68.471M -55.78% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -810K | -68.702M -8,381.73% | N/A 64.92% | N/A -19.04% | N/A -20.43% | N/A 21.31% | N/A 19.74% | ||
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | -1.81 67.85% | N/A 81.97% | N/A 18.75% | N/A 7.69% | N/A -11.00% | N/A -13.22% |
All data in USD
| Q4 / 22 | |
|---|---|
| EPS Q2Q % growth | -0.20 50.24% |
| Revenue Q2Q % growth | |
| EBITDA Q2Q % growth | N/A |
| EBIT Q2Q % growth | -8.659M 51.20% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2022 Q2Q % growth | -0.16 57.89% | -0.20 | 0.04 | 21.57% |
| Q1 2022 Q2Q % growth | -0.35 40.68% | -0.31 | -0.04 | -13.81% |
| Q4 2021 Q2Q % growth | -0.41 65.94% | -0.51 | 0.10 | 19.20% |
| Q3 2021 Q2Q % growth | -0.43 | -0.48 | 0.05 | 10.94% |
| Q2 2021 Q2Q % growth | -0.38 | -0.41 | 0.03 | 6.86% |
| Q1 2021 Q2Q % growth | -0.59 | -0.37 | -0.22 | -58.47% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | N/A | 0% | N/A |
| Revenue | N/A | N/A | N/A | N/A |